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Abstract
Idiopathic pulmonary fibrosis (IPF) is characterized by activation and injury of epithelial
cells, the accumulation of connective tissue and changes in the inflammatory microenviron-
ment. The bone morphogenetic protein (BMP) inhibitor protein gremlin-1 is associated with
the progression of fibrosis both in human and mouse lung. We generated a transgenic
mouse model expressing gremlin-1 in type II lung epithelial cells using the surfactant protein
C (SPC) promoter and the Cre-LoxP system. Gremlin-1 protein expression was detected
specifically in the lung after birth and did not result in any signs of respiratory insufficiency.
Exposure to silicon dioxide resulted in reduced amounts of lymphocyte aggregates in trans-
genic lungs while no alteration in the fibrotic response was observed. Microarray gene
expression profiling and analyses of bronchoalveolar lavage fluid cytokines indicated a
reduced lymphocytic response and a downregulation of interferon-induced gene program.
Consistent with reduced Th1 response, there was a downregulation of the mRNA and pro-
tein expression of the anti-fibrotic chemokine CXCL10, which has been linked to IPF. In
human IPF patient samples we also established a strong negative correlation in the mRNA
expression levels of gremlin-1 and CXCL10. Our results suggest that in addition to regula-
tion of epithelial-mesenchymal crosstalk during tissue injury, gremlin-1 modulates inflam-
matory cell recruitment and anti-fibrotic chemokine production in the lung.
PLOS ONE | DOI:10.1371/journal.pone.0159010 July 18, 2016 1 / 20
a11111
OPEN ACCESS
Citation: Koli K, Sutinen E, Rönty M, Rantakari P,
Fortino V, Pulkkinen V, et al. (2016) Gremlin-1
Overexpression in Mouse Lung Reduces Silica-
Induced Lymphocyte Recruitment – A Link to
Idiopathic Pulmonary Fibrosis through Negative
Correlation with CXCL10 Chemokine. PLoS ONE 11
(7): e0159010. doi:10.1371/journal.pone.0159010
Editor: Bernhard Ryffel, French National Centre for
Scientific Research, FRANCE
Received: April 25, 2016
Accepted: June 25, 2016
Published: July 18, 2016
Copyright: © 2016 Koli et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
The microarray data have been deposited in NCBI
Gene Expression Omnibus (GEO) database and are
accessible through GEO Series accession number
GSE80406.
Funding: KK and MM are supported by the Jane and
Aatos Erkko foundation, the Sigrid Jusélius
Foundation and the University of Helsinki Research
Fund. KK is supported by the Magnus Ehrnrooth
foundation. MM is supported by the Helsinki
Introduction
Gremlin-1, also known as Drm, is a gene involved in kidney and lung branching morphogen-
esis and in bone development [1]. It is a glycosylated cysteine knot protein and belongs to the
DAN family of bone morphogenetic protein (BMP) inhibitors [2]. Gremlin-1 binds with
high affinity to BMP-2 and -4 and with lesser affinity to BMP-7 [3]. This binding blocks
receptor association and signaling by the BMP isoforms. During development inhibition of
BMP-4 signaling by gremlin-1 is crucial for the proximal-distal patterning in the lung. Grem-
lin-1 knockout mice die in utero due to the lack of kidneys and lung septation defects [1].
Overexpression of gremlin in the distal lung epithelium under the surfactant protein C
(SP-C) promoter leads to proximalization of distal lung tubules [4]. These studies suggest
that gremlin-1 is crucial for the epithelial-mesenchymal feedback signaling during lung
development.
Gremlin-1 expression has been associated with many diseases, which are characterized by
reactivation of embryonic programs. In normal adult lung gremlin-1 expression is low [5].
We have shown high gremlin levels in the lungs of idiopathic pulmonary fibrosis (IPF)
patients and this correlates with poor pulmonary function tests [5, 6]. IPF is an aggressive
form of pulmonary fibrosis characterized by scar formation, activation of alveolar epithelial
cells, accumulation of fibroblasts and extracellular matrix leading to loss of lung function.
Rescue of BMP signaling by administration of BMP-7 or tilorone reduces significantly fibrosis
in an experimental silica-induced fibrosis in mice [7, 8]. Furthermore, Farkas et al. [9] have
shown that transient overexpression of gremlin-1 in rat lung results in epithelial activation
and the appearance of fibroblastic foci, highlighting the role of gremlin-1 in fibrosis
development.
Gremlin-1 and aberrant BMP signaling has been functionally linked to fibrosis also in the
kidney, heart and liver [10–12] as well as fibrotic complication in the eye [13]. It also plays
an important role in pulmonary hypertension [14]. In addition, recent studies also indicate
an upregulation of gremlin-1 in epithelial cancers including lung carcinomas [15, 16]. We
have shown that gremlin-1 is involved in the regulation of cell plasticity and chemoresistance
in mesothelioma [17]. Inhibition of BMP-mediated signaling plays an important role during
development and disease progression. By blocking the differentiation inducing BMP signals
gremlin-1 allows proliferation and maintains stem cell properties [18]. On the other hand,
gremlin-1 induces an epithelial-to-mesenchymal transition (EMT) phenotype in cells, which
is involved in fibrotic processes and cancer cell migration, invasion and chemoresistance [5,
19]. This is likely mediated partly by BMP-independent functions of gremlin-1. Gremlin-1 is
also a proangiogenic factor stimulating endothelial cells in a BMP-independent manner
[20]. Both pro- and anti-inflammatory functions have been described for gremlin-1. It can
inhibit monocyte migration by interacting with Slit proteins [21] and block macrophage dif-
ferentiation by interacting with macrophage inhibitory protein (MIF) [22, 23]. Pro-inflam-
matory response has been described in endothelial cells through VEGFR2 activation [24]
indicating that modulation of inflammation associated processes is highly context
dependent.
Here, we produced a transgenic mouse with type II epithelial cell specific overexpression of
gremlin-1 to study adult lung homeostasis and injury responses. Surprisingly, gremlin-1 did
not induce fibrosis or potentiate particulate-induced fibrosis. Gremlin-1 is shown to regulate
inflammatory interferon responses and anti-fibrotic chemokine production in response to par-
ticulate exposure, which is a new pro-fibrotic mechanism of action for gremlin-1.
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Materials and Methods
Antibodies
The antibody against mouse gremlin was from R&D Systems (Minneapolis, MN; AF956). Anti-
bodies used for the detection of lymphocytes were from BD Biosciences (Franklin Lakes, NJ;
anti-CD4, clone H129.19; anti-CD8, clone 53–67) and eBioscience (San Diego, CA; anti-
CD45R, clone RA3-6B2). CD11b antibody was from Abcam (Cambridge, UK; EPR1344) and
myeloperoxidase antibody form Santa Cruz (M-17).
Construction of SPC+loxP-PGK-tn5-NEO-pA-loxP-mGremlin1-pA
plasmid
Gremlin-1 cDNA was cloned under the 3.7-kb hSPC-promoter (kindly provided by Jeffrey
Whitsett, Perinatal Institute, Cincinnati, OH [25]). A loxP-PGK-tn5-NEO-Stop-loxP cassette
(GeneBridges, Heidelberg, Germany) was cloned between gremlin-1 cDNA and hSPC pro-
moter with Red/ET recombineering [26].
Transgenic mice and tissue preparation
All experiments involving animals were approved by the Provincial State Office of Southern
Finland (ESAVI/871/04.10.03/2012) and carried out in accordance with institutional guide-
lines, which fulfill the requirements defined in regulations of the Finnish Act on the Protection
of Animals used for Scientific or Educational Purposes (497/2013) and were performed accord-
ing to the 3R. Age and sex-matched animals were used in all experiments.
The SPC-lox-gremlin1 transgenic mouse strain was produced by pronuclear injection in a
C57BL/6N background at the Turku Center for Disease Modeling (University of Turku, Fin-
land). From 5 transgenic lines number #105 was estimated by quantitative PCR analyses to
have the highest transgene copy number (4–5) and was selected for further characterization.
This SPC-lox-gremlin1 strain has been archived in the European Mouse Mutant Archive
EMMA (EM:08364). The mice were crossbread with R26CreERT strain [27] and the litters
genotyped by using Phire Animal Tissue Direct PCR Kit (Thermo Fisher Scientific, Waltham,
MA) and the following primers (Oligomer, Helsinki, Finland): For 5’-TTC CCT GCC ACA
GTC TGA GAG C-3’ and Rev 5’ GGC GGA TTT GTC CTA CTC AGG AGA GCG-3’ for
SPC-lox-gremlin1 as well as For 5’-GCA CGT TCA CCG GCA TGA AC-3’ and Rev 5’-CGA
TGC AAC GAG TGA TGA GGT-3’ for R26CreERT. During the initial characterization double
positive mice were treated with tamoxifen (Sigma-Aldrich, St. Louis, MO; 50 mg/kg/day ip.,
five consecutive days) to induce Cre-mediated recombination. Deletion of the floxed NEO cas-
sette from SPC-lox-gremlin1 was monitored using the following primers: For 5’-GGC TTG
GTC CTT CAC CTC TGT-3’ and Rev 5’-GTG TGA CCA TCA TGG TGG TGA AC-3’.
Tamoxifen treatment was omitted from further experiments due to the activation of gremlin
expression also without tamoxifen. The mice were euthanized using carbon dioxide. The left
lung was split into two symmetrical pieces, where one piece was fixed in 4% PFA, and the other
processed for frozen sections.
In vivo silica exposure and histological scoring
Wild type and transgenic mice were exposed to silicon dioxide (silica) (Sigma, St. Louis, MO,
2.5 mg/50 μl sterile PBS). Two subsequent oropharyngeal aspiration doses were given on days
0 and 3 of the experiment to ensure even exposure of all animals. In the first experiment 4
months old mice were followed up after 2 months of silica-exposure and sacrificed (n = 5 in
each group). In an independent, shorter experiment the mice were exposed to silica from 4
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weeks to 6 weeks of age (n = 8 in each group). At sacrifice, the entire left lung was collected for
histological analysis (fixed in 4% PFA and embedded in paraffin for sectioning). The entire
right lung was frozen in dry ice and later homogenized for further analysis.
When present, the total number of lymphocytic foci were calculated from each lung section.
The remaining inflammatory cells (mainly neutrophils and occasional eosinophils) were calcu-
lated semi-quantitatively. Grading was from 0–4: 0. no inflammation, 1. few scattered inflam-
matory cells, 2. few inflammatory cell foci and scattered inflammatory cells, 3. many
inflammatory cell foci throughout the lung, and 4. severe inflammation throughout the lung
tissue. Fibrosis was scored with a similar grading from 0–4: 0. no fibrosis, 1. few small fibrotic
foci without interruption of the lung architecture, 2. moderate fibrosis with several larger
fibrotic foci, 3. heavy fibrosis with large fibrotic patches and disruption of normal lung archi-
tecture, and 4. intense fibrosis with significant derangement of the lung parenchyma. Scoring
of fibrosis was performed by two observers who scored blindly and independently all samples.
Pleural thickening was quantitated separately using a similar scoring system from 0–4. 2–3 sec-
tions / mouse left lung were analyzed. All animals from all different groups were analyzed, and
the mean value of each scoring was used for statistical analysis.
Collection and analyses of bronchoalveolar lavage (BAL) fluid
Bronchoalveolar fluid lavage was performed to euthanized mice by cannulating the trachea
and washing with 2x300 μl PBS. Differential cell counts were obtained by microscopy of May-
Grünwald-Giemsa-stained cytocentrifuge preparates: 150 μl BALF was loaded to cytospin
chambers containing Superfrost Ultra Plus glass slides (Menzel GmbH & Co KG, Braun-
schweig, Germany) and centrifuged for 8 minutes, 500 rpm.
Equal volumes of BALF from three silica-treated wild type or transgenic mice were pooled
and used to analyze differences in cytokine levels. Commercial Mouse Cytokine Array Panel A
was from R&D Systems and used according to the manufacturer’s instructions. Quantity One
version 4.6 (BioRad, Hercules, CA) was used for quantification. The results are expressed as
averages of two replicates.
Immunohistochemistry and immunofluorescence
Paraffin-embedded tissue samples were processed and stained using the Novolink Polymer
Detection System (Novocastra, Leica Biosystems, Newcastle upon Tyne, UK) and visualized by
diaminobenzidine (DAB, Vector Laboratories) as described previously [28]. For CD11b,
CD45R and myeloperoxidase staining, the formalin-fixed paraffin embedded specimens were
stained on Leica BOND-MAX fully automated staining system as defined in the manufactur-
er’s staining protocol [with the Leica Bond Polymer Refine Detection-kit, Bond Epitope Retrie-
vel Solution 2, 20 mins, R.T.U. Normal Horse serum 2,5% (Vector Laboratories, Burlingame,
CA) blocking] or manually by using Vectastain Elite ABC Kit (RatIgG) (Vector Laboratories,
Burlingame, CA) and ImmPRESS (Anti-Goat IgG) Kit (Vector Laboratories, Burlingame, CA).
Images of IHC sections were captured with Nikon DS-Fi1 (Nikon, Amsterdam, Netherlands).
Immunofluorescence staining of frozen lung tissue sections was done using gremlin-1, anti-
CD4 or anti-CD8a primary antibodies. Visualization was performed with Alexa Fluor 488 or
Alexa Fluor 568 conjugated secondary antibodies (Invitrogen, Thermo Fisher Scientific, Wal-
tham, MA USA) followed by mounting with a Vectashield Hardset Mounting medium with
DAPI (Vector Laboratories, Burlingame, CA). Gremlin-1 staining was performed from lung
tissue of all animals included in experiments to ensure that the transgene was expressed as
expected.
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Western blotting
Pulverized lung tissue was lysed in RIPA buffer containing Pierce protease inhibitor cocktail
(Thermo Scientific, Rockford, IL). Equal amounts of protein were separated by SDS-PAGE
using 4–20% gradient Tris-HCl polyacrylamide gels (Bio-Rad). Electrophoretically separated
proteins were transferred to nitrocellulose membranes using semi-dry blotting system (Bio-
Rad). Immunodetection was carried out as described [7].
RNA isolation and quantitative RT-PCR
Total RNA from tissue or cells was isolated using RNeasy Mini kit (Qiagen, Hilden, Germany)
and reverse transcribed to cDNA using iScript cDNA synthesis Kit (Bio-Rad, Hercules, CA)
according to the manufacturer's instructions. The cDNAs were amplified using TaqMan
Assays-on-Demand gene expression products (Applied Biosystems, Waltham, MA) and
CFX96 Real-time PCR detection system (Bio-Rad). The relative gene expression differences
were calculated with the comparative delta delta cycle threshold (ΔΔCT) method and the
results have been expressed as mRNA expression levels normalized to the levels of a gene with
a constant expression (TBP, TATA-binding protein). The results are expressed as box plots,
where the middle bar represents median and the upper and lower boundaries of the
box represent the 25th and 75th percentile of the values. The whiskers in box plots represent
minimum and maximum values.
Transcriptional profiling and data analysis
Total RNA from lung tissue was isolated using RNeasy Mini kit (Qiagen). RNA integrity was
confirmed using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Gene
expression analysis (n = 4 in each group) was performed using Agilent SurePrint G3 Mouse
Gene Expression 8x60K microarrays according to the manufacturer’s instructions at the Bio-
medicum Functional Genomic Unit (Helsinki, Finland). The microarray data have been depos-
ited in NCBI Gene Expression Omnibus (GEO) database [29] and are accessible through GEO
Series accession number GSE80406. Raw data was quality checked according to the Agilent
standard procedures. The median foreground intensities were imported into the R software
version 3.0.0 (http://cran.r-project.org) [30] and analyzed with the BioConductor package
limma [31]. Log2 transformation and quantile normalization was performed on the single
channel data separately, according to the suggestions by Smyth and Altman [32]. Background
correction was not carried out, as suggested by Zahurak et al. [33]. Differentially expressed
genes were identified by using linear models and empirical Bayes pairwise comparisons [34].
The functional categorization of DE genes was performed using a novel R-based package
namely BACA [35]. It queries the DAVID knowledgebase and build a charts showing multiple
enrichment analysis results across different conditions/treatments. Each annotation in the
chart is represented as a circle (or bubble) that has a size, indicating how many genes in a list of
DE genes are associated with it, and a color indicating whether the genes are down- (default
color is green) or up- (default color is red) regulated.
Human tissue samples
Written informed consent from patients and an approval for collecting clinical samples was
received from the Helsinki University Hospital Ethics Board (HUS 426/13/03/01/09). The
study was conducted according to the principles outlined in the Declaration of Helsinki. A per-
mission to use tissue samples from deceased patients was obtained from the national
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supervisory authority of welfare and health (3317/05.01.00.06/2011). Patient characteristics
and details have been published in [36].
Cell culture
CCL-190 normal lung fibroblasts and CCL-191 and CCL-134 IPF fibroblasts were obtained
directly from ATCC (Manassas, VA). IPF fibroblasts named UIP-IV fibroblasts were isolated
as previously described [5]. All cells were cultured in Dulbecco’s Modified Eagles’s Medium
(Sigma) supplemented with 10% fetal bovine serum (Gibco, Paisley, UK) and antibiotics
(Gibco).
Statistical analysis
All comparisons were made using nonparametric tests with SPSS version 23 software (IBM).
Multiple group comparisons were made using Kruskal-Wallis test, and two-group comparisons
were made using Mann-Whitney U-test. Correlation coefficients (Spearman) were calculated
using SPSS. P values below 0.05 were considered statistically significant.
Results
Transgenic expression of gremlin-1 in mouse lung
To study the effects of gremlin-1 overexpression on adult lung homeostasis and injury repair, a
transgenic mouse expressing gremlin-1 under the surfactant protein C (SPC)-promoter was
generated. Since gremlin-1 expression is critical for lung development [1], we used the Cre-
LoxP system for the activation of transgenic gremlin-1 expression in adult lung (Fig 1A, see
Methods). SPC-lox-gremlin1 mouse was crossed with the Rosa26-CreERT2 mouse expressing
the Cre recombinase fused to mutant estrogen receptor [27]. Mice positive for both transgenes
are from hereon called gremlin-1 transgenic mice. Western blotting of tissue lysates indicated
that gremlin-1 was abundantly expressed in transgenic lungs but not in the kidneys suggesting
specific targeting of protein expression to the lung by the SPC-promoter (Fig 1B). Gremlin-1
expression was not activated in SPC-lox-gremlin1 mice without the Cre transgene (Fig 1B). To
our surprise, tamoxifen treatment was not needed to activate the transgene expression. This
suggests that some of the robustly expressed CreERT2 fusion protein probably enters the
nucleus and induces the recombination event even in the absence of tamoxifen. Gremlin-1
localization was then studied by immunofluorescence staining of lung tissue. In wild type mice
gremlin-1 was not detectable. In transgenic mice the staining pattern was consistent with alveo-
lar type II cell localization of gremlin-1 in 6 week old mice (Fig 1C). The transgene expression
was activated after birth. At E17 no gremlin-1 staining was observed, whereas at P0 low inten-
sity staining was detected. Thereafter gremlin-1 staining was clearly seen in transgenic lungs
(S1 Fig).
Gremlin-1 transgenic mice were viable and the phenotypic changes observed were very
mild. Mice did not show differences in body weight, signs of respiratory insufficiency or any
notable alterations in well-being (data not shown). Histological staining of lung tissue indicated
slight pleural thickening and possible alveolar space enlargement at 6 month old animals (Fig
2A and Table 1). Since gremlin-1 was expressed soon after birth, it is possible that these alter-
ations were caused by interference with postnatal lung development. Occasionally, in some of
the one year old transgenic animals we observed aberrantly localized arterial structures in the
peripheral lung.
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Reduced lymphocyte recruitment after silica-exposure in gremlin-1
transgenic mice
As we have previously shown that gremlin-1 overexpression is related to human IPF progres-
sion, we studied the response of gremlin-1 transgenic mice to exposure to silicon dioxide (sil-
ica), a fibrosis-inducing particulate matter. Oropharyngeal aspiration of silica induces a
neutrophilic inflammatory response which is followed by progressive lung fibrosis without
Fig 1. Generation of gremlin-1 transgenic mice. A. Schematic representation of the breeding strategy. B. SPC-lox-gremlin-1 mice were
crossbread with Rosa26CreERT mice. Part of the mice were treated with tamoxifen for five days before they were sacrificed. Tissue DNA
was isolated followed by genotyping for SPC-loxP-gremlin1 (floxed) and R26CreERT2. The recombination event was monitored using
primers surrounding the NEO cassette (deleted). Results of SPC-lox-gremlin-1/ R26CreERT2 positive (+/+) and SPC-lox-gremlin-1/-
positive (+/-) mice are shown. Expression of gremlin-1 protein was analyzed usingWestern blotting of lung and kidney tissue lysates. C.
Gremlin-1 protein expression was analyzed by immunofluorescence staining of frozen lung tissue sections. Original magnification 200x.
WT = wild type mice; TG = gremlin-1 transgenic mice.
doi:10.1371/journal.pone.0159010.g001
Gremlin-1 and Regulation of Fibrosis-Related Inflammation and Cytokine Production
PLOS ONE | DOI:10.1371/journal.pone.0159010 July 18, 2016 7 / 20
Fig 2. Reduced amount of inflammatory cell aggregates in gremlin-1 transgenic lung. A. Histological sections of gremlin-1
transgenic and wild type lung showing pleural thickening (original magnification 400x) and alveolar space enlargement (original
magnification 100x) at 6 months of age. Results of histological scoring are presented in Table 1. B. Mice were treated with silica for 2
months and sacrificed at 6 months of age. Collagen 1 (Col1A1), collagen 3 (Col3A1) and tenascin-C (Tnc) mRNA expression levels
analyzed from lung tissue RNA using quantitative RT-PCR (n = 4). The results are presented as box blots. The p values were
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affecting animal mortality or well-being [36, 37]. Transgenic and wild type mice were exposed
to silica at the age of 4 months, sacrificed after two months and analyzed for alterations in
inflammatory and fibrotic responses. Gremlin-1 overexpression was not associated with an
increased fibrotic response at two months after exposure. Histological fibrosis score was not
different between silica-exposed transgenic and wild type mice (Table 1). Interestingly, there
was reduced expression of some extracellular matrix genes (Col1A1 and Tnc) indicating subtle
changes in the fibrotic response (Fig 2B). Tnc showed a trend towards decreased expression
also in non-exposed transgenic mice. In 8 week old transgenic mice a similar, statistically sig-
nificant, decrease was noted (S2A Fig).
Neutrophils were stained from lung tissue sections using myeloperoxidase as a marker. Sil-
ica-treated transgenic lungs showed decreased myeloperoxidase staining score (1.87 ± 0.31
SEM), but the difference to wild type lungs (2.69 ± 0.08 SEM) was not statistically significant.
Scoring of inflammatory cell aggregates in lung tissue sections indicated a reduced number of
mononuclear cell aggregates in transgenic mice (Table 1, Fig 2C), indicating that gremlin-1
expression modulates the pulmonary inflammatory response to particulate exposure. Staining
of silica treated wild type lung tissue with CD4 and CD8 T-cell markers as well as CD45R
(B220) antibody, which recognizes mainly B-cells, indicated that both T- and B-lymphocytes
were found in the aggregates (Fig 2D).
Reduced interferon induced gene program in transgenic lungs
Microarray analysis was performed to characterize changes in gene expression in non-exposed
or silica-exposed transgenic and wild type animals (see Methods). Gremlin-1 expression levels
in lung tissue samples were determined by qPCR analyses since the microarray did not contain
a probe that would recognize the transgene. Grem1mRNA levels were high in transgenic lungs
as expected (S2B Fig). Only few genes were differentially expressed in transgenic lungs com-
pared to wild type lungs, which is consistent with the minor histological findings (Fig 3A,
Table 2 and S2C and S3 Figs). Silica exposure-induced robust changes in gene expression levels
in both transgenic and wild type mice. The array results were visualized with a graphical BACA
tool utilizing DAVID annotations [35]. Consistent with reduced lung inflammatory response,
it was noted that immune response and immunity-related annotations were much less enriched
in transgenic silica-exposed lungs (Fig 3B). Especially lymphocyte activation and cytokine pro-
duction-related annotations were notably decreased. In addition, endogenous expression of
calculated using the Kruskal-Wallis test or the Mann-Whitney U-test when comparing two groups. WT = wild type mice; TG = gremlin-1
transgenic mice. C. Representative histological pictures showing decreased amount of inflammatory cell aggregates in silica-treated
gremlin-1 transgenic mice. Original magnification 200x, inset original magnification 400x. D. Immunofluorescence staining of wild type
frozen lung tissue sections using CD4 and CD8 T-cell markers. DAPI staining was used to visualize the nuclei. Immunohistochemical
staining of CD45R/B220 (brown color) is shown on the right.
doi:10.1371/journal.pone.0159010.g002
Table 1. Histological scoring.
Fibrosis /score Emphysematous structures/score Pleural thickening/score Inﬂammatory cells/aggregates per section
WT 0 0,63±0,13 0,50±0,29 0,5±0,29
TG 0,13±0,13 1,38±0,52 1,63±0,38a 0,25±0,25
WT+silica 2,38±0,24 0,25±0,25 0,75±0,32 12,75±4,84
TG+silica 2,00±0,32 1,50±0,35b 1,30±0,12a 4,0±3,03b
a p = 0.06 compared to WT or WT + silica;
b p < 0.05 compared to WT + silica
doi:10.1371/journal.pone.0159010.t001
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Fig 3. Reduced inflammatory gene response to silica. A. Gene expression microarray was performed using lung
tissue mRNA isolated from 6 months old mice (n = 4 in each group). The number of upregulated or downregulated genes
are indicated. B. Bubble plots for all immune-related annotations. It compares the most significant Gene Ontology (GO)
terms from the “Immune-related Biological Process” ontology found across the different experimental conditions. The
same selection strategy was applied for all conditions, which was a significance threshold of 0.05 for the adjusted
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Grem1 was upregulated in both wild type and transgenic lungs, which is in agreement with our
previous studies (S3 Fig) [8].
Analyses of differentially expressed genes in silica-exposed mice indicated 38 upregulated
and 45 downregulated genes in transgenic animals (>1.5-fold change, Table 3, S3 Fig). Most of
the downregulated genes were linked to inflammatory responses (Fig 3B and 3C, Table 3).
Quantitative RT-PCR verification was performed for selected genes (Fig 3C and S2B Fig). Espe-
cially interferon regulated genes, such asMx1, Rsad2, Ifi44 and Stat2 were significantly less
induced by silica exposure in transgenic mice. The expression of these genes also correlated
with the amount of lymphocyte aggregates in the lung. In agreement, Ifng expression was sig-
nificantly induced in wild type but not in transgenic silica-exposed mice (S3 Fig and Fig 3C).
Direct comparison on silica-treated samples showed a clear trend of reduced Ifng expression
(Fig 3C). Th1-cell surface marker Cxcr3 was upregulated in wild type lung but not in transgenic
lung following silica exposure, while a moderate induction of the Th2-cell surface marker Ccr4
was observed in both (S3 Fig). These results are consistent with reduced Th1 inflammatory
response in gremlin-1 transgenic lungs.
Interestingly, several circadian clock transcription factors were differentially expressed in
transgenic animals. Upregulation of negative regulators Nr1d2 and Per3 as well as downregula-
tion of a central positive regulator Arntl/Bmal1 was observed (Fig 3C and S2 Fig). In addition,
Dbp was the most upregulated gene in transgenic silica-exposed lung. These findings link per-
turbations in circadian clock genes to gremlin-mediated inflammatory and tissue injury
responses in the lung [38].
Reduced chemokine levels in transgenic lungs after silica exposure for
two weeks
To focus on the regulation of lung inflammatory responses by gremlin-1 expression, we per-
formed a new in vivo experiment at an earlier time point, where inflammatory responses are
expected to dominate. Two weeks after silica exposure, BAL fluid and lung tissue were collected
for analysis of inflammatory cells and cytokines. Differential counts of BAL fluid cells indicated
enrichment p-value, at least five genes from the input list in the enriched category and the whole genome as reference
background. C. and D. Quantitative RT-PCR analyses of selected genes identified as differentially expressed in the
microarray. The results are presented as box blots. The p values were calculated using the Mann-Whitney U-test (at 2
weeks n = 8; at 2 months n = 4). WT = wild type mice; TG = gremlin-1 transgenic mice.
doi:10.1371/journal.pone.0159010.g003
Table 2. Top genes differentially regulated in gremlin-1 transgenic lung.
Gene logFC TG/WT P.Value
Angptl4 Angiopoietinlike-4 1.08 0.0077
Pdk4 Pyruvate dehydrogenase kinase, isozyme 4 0.96 0.0042
Upk3a Uroplakin 3A 0.81 0.0040
Calcr Calcitonin receptor 0.77 0.0032
Lamc3 Laminin, gamma 3 0.64 0.0013
Rab6b RAB6B, member ras oncogene family -1.12 0.0027
Chst8 Carbohydrate (N-acetylgalactosamine 4–0) sulfotransferase 8 -0.82 0.0013
Wif1 WNT inhibitory factor 1 -0.76 0.0066
MMP3 Matrix metallopeptidase 3 -0.60 0.0010
Absolute Log2 fold change and p-values are shown for comparison of transgenic (TG) and wild type (WT) lungs.
doi:10.1371/journal.pone.0159010.t002
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a tendency towards reduced percentage of lymphocytes in silica-treated transgenic mice
(p = 0.108) (Table 4).
Monocyte marker CD11b-staining was increased in silica treated lung tissue, but no differ-
ence was observed in the staining scores between wild type (3.25 ± 0.16 SEM) and transgenic
(3.21 ± 0.32 SEM) lung (Fig 4A). CD11b is expressed in the surface of many leukocytes includ-
ing monocytes, macrophages, natural killer cells and neutrophils, which suggests that gremlin-1
Table 3. Top genes differentially regulated in gremlin-1 transgenic lung.
Gene logFC TG silic/WT silica P.Value
Dbp D site of albumin promoter binding protein 2.29 0.0007
Chi3l4 Chitinase 3-like 4 1.36 0.0007
Nr1d2 Nuclear receptor subfamily 1, group D, member 2 1.25 0.0007
Gm6522 Chitinase 3-like 3 pseudogene 1.22 0.0002
Cyp2e1 Cytochrome P450, family 2, subfamily E, polypeptide 1 1.15 0.0014
Sftpb Surfactant protein B 1.00 0.0022
Ces1g Carboxylesterase 1G 0.99 0.0021
Cd207 CD207 molecule, langerin 0.94 0.0032
Tff2 Trefoil factor 2 0.92 0.0048
Calcr Calcitonin receptor 0.91 0.0009
Lrat Lecithin retinol acyltransferase 0.87 0.0012
Tspan4 Tetraspanin 4 0.87 0.0069
Ear11 Eosinophil-associated, ribonuclease A family, member 11 0.86 0.0061
Chi3l3 Chitinase 3-like 3 0.85 0.0001
Per3 Period circadian clock 3 0.85 0.0048
Klra2 Killer cell lectin-like receptor, subfamily A, member 2 -1.19 0.0006
Arntl Aryl hydrocarbon receptor nuclear translocator-like -1.09 0.0034
Oas2 2'-5'-oligoadenylate synthetase 2, 69/71kDa -1.07 0.0032
Cr2 Complement component (3d/Epstein Barr virus) receptor 2 -1.01 0.0087
Rsad2 Radical S-adenosyl methionine domain containing 2 -0.92 0.0017
Nrcam Neuronal cell adhesion molecule -0.89 0.0001
Pydc3 Pyrin domain containing 3 -0.88 0.0065
Bst2 Bone marrow stromal cell antigen 2 -0.86 0.0017
Mx1 Mx dynamin-like GTPase 1 -0.85 0.0017
Isg15 ISG15 ubiquitin-like modiﬁer -0.84 0.0039
Ccnjl Cyclin J-like -0.84 0.0005
Gdpd2 glycerophosphodiester phosphodiesterase domain 2 -0.83 0.0023
Apol9b Apolipoprotein L 9b -0.82 0.0098
Klrd1 Killer cell lectin-like receptor subfamily D, member 1 -0.79 0.0017
Iﬁ44 Interferon-induced protein 44 -0.77 0.0035
Absolute Log2 fold change and p-values are shown for comparison of silica-treated transgenic (TG) and wild type (WT) lungs.
doi:10.1371/journal.pone.0159010.t003
Table 4. Differential cell counts.
BAL cells %±SD Monocytes /macrophages Neutrophils Lymphocytes Atypical lymphocytes Eosinophils
WT 95.2 ± 9.0 0.3 ± 0.5 4.5 ± 8.7 0 0
TG 97.9 ± 12.2 1.1 ± 0.8 0.8 ± 1.0 0 0.2 ± 0.4
WT+silica 50.6 ± 12.2 36.0 ± 14.4 12.0 ± 7.5 0.5 ± 1.4 0
TG+silica 42.6 ± 17.3 45.1 ± 18.7 7.9 ± 4.3 0.9 ± 1.2 0.1 ± 0.4
doi:10.1371/journal.pone.0159010.t004
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does not alter the overall innate immune response to silica. Gremlin-1 has been reported to
inhibit MIF and macrophage differentiation as well as monocyte migration [22, 21]. Therefore,
we analyzed the mRNA expression levels ofMif and Tnf, which is mainly produced by mono-
cytes/macrophages in the lung. Differences in wild type versus transgenic expression were not
observed (Fig 4B). These results indicate that gremlin-1 expression alters the lung inflammatory
response by primarily reducing the recruitment of lymphocytes, instead of monocytes/macro-
phage-related mechanisms at the measured time point. Consistent with this, gene array results
after two-month silica exposure indicated equal induction of Cd68 and Cd14monocyte/macro-
phage markers in lung tissue (S3 Fig). At two monthsMif expression was not altered in trans-
genic lungs, however, Tnf showed a trend towards decreased expression at this time point
(Fig 4B).
Fig 4. Gremlin-1 does not alter the overall innate immune response to silica. A. Immunohistochemical staining of lung tissue sections using CD11b
antibody after two-week silica-exposure. Original magnification 200x. Staining scores are indicated below the photomicrographs (mean ± SEM, n = 8).
B. Quantitative RT-PCR analyses of macrophagemigration inhibitory factor (Mif) and tumor necrosis factor-α (Tnf) after two-week (n = 8) or two-month
(n = 4) silica-exposure. The results are presented as box blots. The p values were calculated using the Mann-Whitney U-test. WT = wild type mice;
TG = gremlin-1 transgenic mice.
doi:10.1371/journal.pone.0159010.g004
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The amount of inflammatory cytokines in BAL fluid was analyzed using a mouse cytokine
array (see Methods). In the BAL fluid of wild type mice exposed to silica for two weeks the
most abundant molecules were sICAM-1, MCP-1/CCL2, IL-1ra, C5/C5a, IP10/CXCL10 and
TIMP-1 (Fig 5A and 5B). In transgenic BAL fluid the levels of several cytokines decreased,
CXCL10 and CCL2 being the most downregulated cytokines. CXCL10 is an antifibrotic and
angiostatic chemokine expressed by monocytes, endothelial and fibroblastic cells and an
important T-lymphocyte chemoattractant [39]. Reduction in the amount of CXCL10, a Th1
cytokine, is in agreement with the observed reduction in lymphocyte recruitment. Further-
more, analysis of lung tissue mRNA expression levels indicated reduced Cxcl10 expression
both at 2 weeks and at 2 months after silica-exposure (Fig 5C). Ccl2mRNA expression in lung
tissue was not significantly reduced (data not shown). CCL2 induces monocyte and macro-
phage migration, but has also anti-fibrotic effects in cultured human fibroblasts [40].
Negative correlation between gremlin-1 and CXCL10 expression in IPF
tissue and cultured fibroblasts
Decreased levels of CXCL10 have been previously associated with IPF [41, 42]. We analyzed
mRNA expression levels of gremlin-1 and CXCL10 in control and IPF patient lung tissue sam-
ples. Gremlin-1 expression increased and CXCL10 expression decreased significantly in IPF
lung tissue (Fig 5D and S4 Fig). A strong negative correlation was found in the expression levels
of CXCL10 and gremlin-1 (rs = -0.891, p = 0.001, n = 10). In addition, cultured fibroblasts iso-
lated from IPF patients showed a similar negative association of mRNA expression levels
(Fig 5E).
Discussion
High gremlin expression has been functionally linked to malignant and fibrotic lung diseases.
In IPF patients gremlin-1 expression levels are high and correlate with poor lung function [5,
6]. Experimental overexpression of gremlin-1 in mouse lung leads to severe developmental
problems [4], which prevents studies on adult lung disease mechanisms. Transient overexpres-
sion of gremlin in rat lung results in epithelial activation and transient fibrotic changes, sug-
gesting a role for gremlin-1 in promoting fibrosis [9]. We generated a transgenic mouse model
to study the role of gremlin-1 in adult lung homeostasis and injury repair. Using the SPC pro-
moter and a Cre-loxP system, gremlin-1 expression was specifically targeted to type II lung epi-
thelial cells. Gremlin-1 transgenic mice were viable and showed no signs of respiratory
insufficiency, indicating that epithelial gremlin-1 expression does not alter adult lung physiol-
ogy. In addition, gene array analysis indicated only few alterations in lung gene expression lev-
els in transgenic mice. Moderate pleural thickening and possible alveolar space enlargement
detected at 6 month old animals were presumably caused by a minor interference with postna-
tal lung development.
Silica-exposed mice develop a neutrophilic inflammatory response and a progressive patchy
lung fibrosis, which has similar features to human IPF. Gremlin-1 expression is induced in
both asbestos- and silica-induced pulmonary fibrosis models [7, 8]. Transgenic overexpression
of gremlin-1 in type II epithelial cells did not induce fibrosis or potentiate silica-induced fibro-
sis when analyzed after two months exposure. We have previously shown that gremlin-1
expression is functionally linked to the progression of fibrosis induced by asbestos-exposure in
mouse lung [7]. In this model, gremlin-1 expression is induced and becomes apparent at day
three after exposure and is significantly increased at two weeks [7]. In our transgenic model,
we did not see any increase in fibrotic response, although in a rat model such effects have been
shown using gremlin overexpression alone [9]. It is possible that the observed decreased
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Fig 5. CXCL10 chemokine levels correlate negatively with gremlin-1 levels in mouse and human lung. A. Inflammatory cytokines in BAL
fluid of wild type and gremlin-1 transgenic mice exposed to silica for two weeks were analyzed using a mouse cytokine array. B. Quantification of
positive array signals. Mean pixel density of the signal in transgenic BAL fluid is divided by the signal in wild type BAL fluid. The error bars represent
standard deviation (n = 2). C. Quantitative RT-PCR analyses of Cxcl10 after two-week or two-month silica-exposure. The results are presented as
box blots. The p value was calculated using the Mann-Whitney U-test (n = 8). WT = wild type mice; TG = gremlin-1 transgenic mice. D. Quantitative
RT-PCR analyses of human gremlin-1 (GREM1) andCXCL10 in control (ctrl) and idiopathic pulmonary fibrosis patient (IPF) lung tissue. E. Cultured
human fibroblasts isolated from control (ctrl) and IPF patient lung tissue (IPF) were analyzed forGREM1 andCXCL10 expression by quantitative
RT-PCR. The error bars represent standard deviation (n = 3).
doi:10.1371/journal.pone.0159010.g005
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lymphocytic response may regulate the following fibrotic response, although it has been sug-
gested that innate immune processes are sufficient for the initiation of silica-induced fibrosis in
mice [37]. There is also a possibility that the effects of gremlin-1 on post-natal lung develop-
ment may be reflected in the adult injury response and development of fibrosis.
Similar to what we observed in the lung, transgenic gremlin-1 expression in mouse kidney
alone has not induce fibrotic alterations or other phenotypic changes [43]. However, proximal
tubular cell expression of gremlin-1 has been found to aggravate kidney fibrosis induced by
streptozotocin [44]. In that particular model tagged human gremlin-1 protein was expressed in
mouse proximal tubular epithelial cell. We expressed mouse gremlin-1 without any tags to
ensure that the transgene functions as the endogenous protein and does not elicit non-specific
responses. However, the results from kidney models suggest that gremlin-1 may act locally and
in a cell and tissue-specific fashion. This is also suggested by the increased levels of pro-inflam-
matory factors observed following injection of recombinant gremlin-1 into the mouse kidney
[24]. Similar to what has been found in endothelial cells [45], gremlin-1 was suggested to
induce renal inflammatory responses through the activation of VEGFR2 in proximal tubular
cells [24]. Anti-inflammatory functions of gremlin-1 have also been reported and include inhi-
bition of monocyte migration and macrophage differentiation through BMP-independent
mechanisms [21, 22]), again suggesting context dependent functions for gremlin-1.
The main new finding in this study was the specific decrease in silica-induced recruitment
of lymphocytes into the gremlin-1 transgenic lung, while there was no obvious alterations in
the overall innate immune response. Consistent with reduced number of lymphocyte aggre-
gates in transgenic lungs, microarray results suggested a clear downregulation of the expression
of inflammatory genes, particularly interferon response pathway genes. A number of genes,
such as Bst2, Rsad2, Ifi44, Oas2 and Stat2, were previously found to be downregulated in pul-
monary fibroblasts from IPF patients and from scleroderma-associated interstitial lung disease
[46]. These results suggest local lung specific decrease in Th1 responses. Our current results
indicate gremlin-1 as an important mediator of this shift in the balance of Th1/Th2 responses,
which is a feature of IPF [47]. IPF and scleroderma patients lung tissue express high levels of
gremlin-1 [5, 48]. A candidate gene for familial IPF, ELMOD2, has also been shown to regulate
anti-viral responses, particularly interferon pathways suggesting a common mechanism [49].
The Th1 chemokine CXCL10 protein levels in the BAL fluid and lung tissue mRNA expression
were found significantly reduced in transgenic silica-exposed mice. CXCL10 is an anti-fibrotic
chemokine and has been strongly linked to the progression of fibrosis in mouse models.
CXCL10 deficient mice exhibit increased pulmonary fibrosis after bleomycin treatment while
overexpression of CXCL10 in mice reduces fibroblast accumulation and fibrosis suggesting
that CXCL10 acts as a protective cytokine in the lung [50]. In gremlin-1 transgenic mice, how-
ever, clear alterations in the progression of fibrosis were not noted.
A number of studies have shown that CXCL10 and its receptor CXCR3 are involved in the
regulation of inflammatory, angiogenic and fibrotic processes also in human lung diseases
[42]. CXCL10 is involved in the selective recruitment of pro-inflammatory Th1-cells, which
are characterized by CXCR3 expression. CXCL10 levels are reduced in IPF patient BAL fluid.
In addition, CD4 positive T-cells in IPF patient BAL fluid have significantly lower CXCR3
expression [42]. CXCL10 is produced by leukocytes, epithelial, endothelial and fibroblastic
cells. It can also inhibit fibroblast migration through CXCR3 receptor independent, syndecan-
4 dependent manner, and this way act as an inhibitor of fibrotic processes [51]. We established
a negative correlation in CXCL10 and gremlin-1 mRNA expression levels in control and IPF
patient lung tissue as well in cultured human lung fibroblasts. Thus, increased gremlin-1 levels
may lead to decreased local CXCL10 mRNA and protein levels in the lung, which contribute to
lymphocyte recruitment and fibroblast migration.
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Another interesting finding was regulation of circadian clock genes by gremlin-1 in silica-
exposed lungs. Inflammatory responses are known to be affected by perturbations of the
molecular clock function, which contributes to lung function in airway diseases. Decline in cir-
cadian function has been linked especially to depression of immune responses and exacerba-
tions in asthma and COPD [38]. Interestingly, gremlin-2 and BMP-signaling was recently
suggested to be regulated by circadian rhythms in the fibrous tissue of tendon [52]. Our find-
ings strength the link between gremlin-1 and downregulation of inflammatory interferon
responses during fibrotic processes. The function of gremlin-1 as a regulator of angiogenic pro-
cesses mediated by VEGFR2 activation may also contribute to lung injury responses and fibro-
genesis. Consistent with this, we noticed that gene array annotations related to blood vessel
development and vasculature development were enriched in transgenic silica-treated lungs.
Interestingly, histological analyses of one year old transgenic mice revealed aberrantly posi-
tioned blood vessels. Further studies are needed to characterize this phenomenon.
The view of the role of inflammation in IPF has gradually changed. Traditional anti-inflam-
matory treatments (steroids) are not effective in IPF, however, it has become clear that immune
cells are present and may contribute to the fibrotic processes in the IPF lung [53]. A shift of
inflammatory balance from lymphocytic to myelomonocytic lineage could even explain the
lack of effect of immunosuppressive therapies in human IPF, where gremlin-1 expression is
abundant [5]. Our results suggest that in addition to regulation of epithelial-mesenchymal
crosstalk during tissue injury, gremlin-1 can potentially modulate inflammatory cell recruit-
ment and chemokine production in the lung making gremlin-1 a potential target for therapeu-
tic intervention.
Supporting Information
S1 Fig. Gremlin-1 protein expression is detected after birth in transgenic mice. Gremlin-1
protein expression was analyzed by immunofluorescence staining of frozen lung tissue sections
prepared at postnatal days 0 (P0) and 1 (P1) as well at 6 weeks. Few very weakly positive cells
could be detected at P0. At P1 gremlin-1 positive cells were clearly detectable, but the intensity
was lower than in adult animals.
(TIF)
S2 Fig. Quantitative RT-PCR analyses of selected genes identified as differentially
expressed in the microarray. Expression of Tnc at 2 weeks (A) as well as Grem1 (B) and
Agnptl4, Dbp, Stat2 and Rsad2 (C) at 2 months are shown. The results are presented as
box blots. The p values were calculated using the Mann-Whitney U-test (n = 4). WT = wild
type mice; TG = gremlin-1 transgenic mice.
(TIF)
S3 Fig. Tables of differentially expressed genes in pairwise comparisons from the microar-
ray experiment. Differentially expressed genes with p-value< 0.01 and absolute log2 fold
change> 0.58 are shown. The NCBI Entrez Gene IDs, gene info and gene symbols are shown.
Additionally, for each significant gene, the average expression across the microarray samples,
the t-test value, the nominal p-value, the adjusted p-value and the B value are reported.
(XLSX)
S4 Fig. Quantitative RT-PCR analyses of gremlin-1 (GREM1) and CXCL10 in control (ctrl)
and idiopathic pulmonary fibrosis patient (IPF) lung tissue. The results are presented as
box blots. The p values were calculated using the Mann-Whitney U-test.
(TIF)
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